OKUR (OnKure Therapeutics) Total Long-Term Assets : $1.71 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. OnKure Therapeutics's Total Long-Term Assets for the quarter that ended in Mar. 2025 was $1.71 Mil.

OnKure Therapeutics Total Long-Term Assets Historical Data

The historical data trend for OnKure Therapeutics's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics Total Long-Term Assets Chart

OnKure Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Total Long-Term Assets

2.38

1.97

1.90

OnKure Therapeutics Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Assets	Get a 7-Day Free Trial					1.82	1.68	0.65	1.90	1.71

OnKure Therapeutics Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

OnKure Therapeutics Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

OnKure Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301

Website

https://www.onkuretherapeutics.com

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.